Burnouf-Radosevich et al., “A therapeutic, highly purified factor XI concentrate from human plasma”, 1992, Transfusion, 32(9), 861-867.* |
Hedner U.: Treatment of patents with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa.: Thromosis and Haemostasis: vol. 82, No. 2, 1999; pp. 531-539. |
Schmidt M.L. et al.: Recombinant activated factor VII therapy for intracranial hemmrhage in hemophilia A patnets with inhibitors: american journal of hematology: vol. 47, No. 1, 1994, pp. 36-40. |